Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia
نویسندگان
چکیده
منابع مشابه
Guillain-Barré syndrome in a patient with chronic lymphocytic leukaemia.
Recovery of adrenocortical function following treatment of tuberculous Addison's disease Sir, Penrice and Nussey report two cases of Addison's disease in which adrenocortical function recovered following treatment of tuberculosis.' Adrenal glands may be enlarged or atrophic in patients with Addison's disease due to t iberculosis. Large glands in tuberculosis mean a recent and probably active in...
متن کاملColonic Involvement in a Patient with Chronic Lymphocytic Leukaemia
Various gastrointestinal infiltrations have been described in patients with chronic lymphocytic leukaemia (CLL). Here, we report a 69-year-old man with CLL and anaemia in whom the macroscopic finding of colonoscopy was normal, but the histological specimens revealed lymphocytic leukemia in ileum and in colon. If a CLL patient has any symptoms suggesting a possible GI manifestation of the haemat...
متن کاملAlemtuzumab in chronic lymphocytic leukemia
QUESTIONS With respect to outcomes such as survival, response rate, response duration, time to progression, and quality of life, is alemtuzumab a beneficial treatment option for patients with B-cell chronic lymphocytic leukemia (cll)?What toxicities are associated with the use of alemtuzumab?Which patients are more likely-or less likely-to benefit from treatment with alemtuzumab? PERSPECTIVES...
متن کاملExperience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.
BACKGROUND Alemtuzumab (MabCampath) is a monoclonal antibody against CD52, indicated as third-line treatment of chronic lymphocytic leukaemia (CLL). As most important side effect opportunistic infections are mentioned. It is, however, unknown whether these complications often lead to problems in general patient care in the Netherlands. METHODS To gain insight into the use and complications of...
متن کاملNorovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia
BACKGROUND Norovirus infection is increasingly recognized as an important cause of persistent gastroenteritis in immunocompromised hosts and can be a potential cause of morbidity in these populations. CASE PRESENTATION Here, we report a case of norovirus-related chronic diarrhea occurring in a 62-year-old immunocompromised patient treated with alemtuzumab for chronic lymphocytic leukemia. Des...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Haematology
سال: 2011
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08802.x